Dr Mohammad Afshar (Founder and CEO) is presenting our Onco KEM® platform at WIN 2015 on 29 June. Dr. Mariana Guergova-Kuras (CTO) and Dr David Morley (VP Computational Technology) will also be attending the symposium for a fascinating two days of cutting-edge presentations and discussions with global key opinion leaders in cancer research and precision cancer medicine. […]
Ariana’s CEO will present the company’s latest developments in data analytics in front of thousands at the French Pavilion. […]
Come and listen to Dr Afshar's presentation "Using Big Data towards personalized treatment selection and multi-marker real time diagnostics"
Dr Mohammad Afshar and the Business Development Team have lined up a a series of one on one meetings at BIO-Europe Spring 2015. Come and meet them !
CEO Mohammad Afshar presents very practical cases of bioinformatics ground breaking use in diagnostics and therapeutic areas. […]
Dr Mohammad Afshar (Founder and CEO) is joining a prestigious panel of industry leaders to discuss the strategy of open data, data intelligence and data management. Genevieve Fioraso, France’s Deputy Minister for Higher Education & Research and Axelle Lemaire, Deputy Minister in charge of digital tech will participate in the session. […]
On September 23, we attended the Big Data in Pharma briefing in London, organized by Terrapin Briefings. Our VP of Computational Technology, Dr David Morley, delivered a talk on “Predictive Diagnostics and Data Mining for Personalised Medicine” and chaired the roundtable discussion on “How to ensure data quality”. […]
KEM® Biomarker case study presented at EACR-23 this week showed that prognostic signatures generated by KEM® Biomarker have better or similar performances to other classification methods in terms of sensitivity and specificity while having significantly lower number of features in the models. […]
Young researchers from Ariana Pharma presented two posters at the recent WIN 2014 Symposium on breakthrough biomarker investigations and combined therapeutic approaches for precision cancer medicine, held in Paris on 23-24 June 2014. […]
Meet Chief Technology Officer Mariana Kuras and Applications Scientist Pilar Schneider at the 23rd Biennial Conference of the European Association of Cancer Research in Munich, Germany between 5th and 8th July. Pilar will be presenting our poster on 'Shorter Multimarker Signatures: a New Tool to Facilitate Cancer Diagnosis' at the poster defence session which will take place between 3:45 and 5:15pm on Monday 7th July.